BiotechTube
Home/Pipeline/MRX-4TZT

MRX-4TZT

Not specified

Not specifiedActive

Key Facts

Indication
Not specified
Phase
Not specified
Status
Active
Company
Medrx

About Medrx

MEDRx is a private, pre-revenue biotech specializing in advanced drug delivery platforms, particularly transdermal and oral systems utilizing ionic liquids and nanocolloids. The company's core technologies, ILTS® and NCTS®, aim to dramatically improve the skin permeability of drugs, while its microneedle array program targets painless delivery of biologics. With a pipeline led by MRX-4TZT and a service-based workflow for partners, MEDRx positions itself as a formulation technology company seeking to bridge the gap between existing active pharmaceutical ingredients and improved patient-friendly products.

View full company profile

Other Not specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved